Lauppe, Rosa, Fredrik O. L. Nilsson, Hanna Fues Wahl, Mathias Lilja, Anders Vikström, and Sandra T. Asanin. 2022. “Use of ALK-Tyrosine Kinase Inhibitors (ALK TKI) in Clinical Practice, Overall Survival, and Treatment Duration – a Swedish Nationwide Retrospective Study”. Acta Oncologica 61 (11):1354-61. https://doi.org/10.1080/0284186X.2022.2133972.